Under the new structure, the global generics and specialty medicines groups will be integrated into a single commercial organization covering North America, Europe and growth markets. Each region will manage the entire portfolio from OTC to specialty and generic pharmaceuticals.
Branded Pharmacy News
The formulation is aimed at meeting the needs of patients with difficulty swallowing.
The vaccine has shown over 90% efficacy across all age groups in the prevention of shingles, a painful and potentially serious disease that affects one in tnree people in the United States.
Bydureon BCise features a continuous-release delivery system that provides consistent levels of the product’s active ingredient, exenatide, to help patients maintain glycemic control, the company said.
Yescarta, from Gilead’s recently acquired company Kite, was approved to treat relapsed or refractory large B-cell lymphoma following two or more lines of systemic therapy.
As specialty growth looks set to plateau, the drug class continues to see its share of per-capita spending increase, with a decline in spending on traditional medicines creating space for more specialty share.
Allergan said that the decision was not the end of the road for their intellectual property protection efforts around Restasis.
The organization has named Amgen chairman and CEO Robert Bradway to the chairman-elect position, effective immediately, and named two more industry executives to the board.
The Food and Drug Administration on Thursday approved Lyrica CR (pregabalin) controlled-release tablets.
Lupin acquired the company for $150 million, bringing into its drug portfolio Symbiomix’s recently approved single-dose treatment for bacterial vaginosis.